| The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version) PS Sidhu, V Cantisani, CF Dietrich, OH Gilja, A Saftoiu, E Bartels, ... Ultraschall in der Medizin-European journal of ultrasound 39 (02), e2-e44, 2018 | 635 | 2018 |
| European position statement on lung cancer screening M Oudkerk, A Devaraj, R Vliegenthart, T Henzler, H Prosch, CP Heussel, ... The Lancet Oncology 18 (12), e754-e766, 2017 | 432 | 2017 |
| Risk factors for diabetes insipidus in langerhans cell histiocytosis N Grois, U Pötschger, H Prosch, M Minkov, M Arico, J Braier, JI Henter, ... Pediatric blood & cancer 46 (2), 228-233, 2006 | 333 | 2006 |
| COVID-19 patients and the Radiology department–advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) MP Revel, AP Parkar, H Prosch, M Silva, N Sverzellati, F Gleeson, ... European radiology 30 (9), 4903-4909, 2020 | 294 | 2020 |
| MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis D Prayer, N Grois, H Prosch, H Gadner, AJ Barkovich American journal of neuroradiology 25 (5), 880-891, 2004 | 240 | 2004 |
| Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial T Sonnweber, S Sahanic, A Pizzini, A Luger, C Schwabl, B Sonnweber, ... European Respiratory Journal 57 (4), 2021 | 229 | 2021 |
| Central nervous system disease in Langerhans cell histiocytosis N Grois, B Fahrner, RJ Arceci, JI Henter, K McClain, H Lassmann, ... The Journal of pediatrics 156 (6), 873-881. e1, 2010 | 224 | 2010 |
| Neuropathology of CNS disease in Langerhans cell histiocytosis N Grois, D Prayer, H Prosch, H Lassmann Brain 128 (4), 829-838, 2005 | 208 | 2005 |
| Langerhans cell histiocytosis in neonates M Minkov, H Prosch, M Steiner, N Grois, U Pötschger, P Kaatsch, ... Pediatric blood & cancer 45 (6), 802-807, 2005 | 159 | 2005 |
| Automatic lung segmentation in routine imaging is primarily a data diversity problem, not a methodology problem J Hofmanninger, F Prayer, J Pan, S Röhrich, H Prosch, G Langs European Radiology Experimental 4 (1), 1-13, 2020 | 143 | 2020 |
| Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation K Hoetzenecker, S Schwarz, M Muckenhuber, A Benazzo, F Frommlet, ... The Journal of thoracic and cardiovascular surgery 155 (5), 2193-2206. e3, 2018 | 124 | 2018 |
| Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis H Prosch, N Grois, D Prayer, F Waldhauser, M Steiner, M Minkov, ... Pediatric blood & cancer 43 (5), 594-599, 2004 | 114 | 2004 |
| Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine AC Aichelburg, J Walochnik, O Assadian, H Prosch, A Steuer, ... Emerging infectious diseases 14 (11), 1743, 2008 | 111 | 2008 |
| Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients ME Mayerhoefer, G Karanikas, K Kletter, H Prosch, B Kiesewetter, ... Clinical Cancer Research 20 (11), 2984-2993, 2014 | 105 | 2014 |
| Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis N Grois, D Prayer, H Prosch, M Minkov, U Pötschger, H Gadner Pediatric blood & cancer 43 (1), 59-65, 2004 | 101 | 2004 |
| Review of cancer treatment with immune checkpoint inhibitors C Thallinger, T Füreder, M Preusser, G Heller, L Müllauer, C Höller, ... Wiener Klinische Wochenschrift 130 (3), 85-91, 2018 | 98 | 2018 |
| ESR/ERS statement paper on lung cancer screening HU Kauczor, AM Baird, TG Blum, L Bonomo, C Bostantzoglou, ... European Radiology 30 (6), 3277-3294, 2020 | 94 | 2020 |
| Pattern and course of neurodegeneration in Langerhans cell histiocytosis M Wnorowski, H Prosch, D Prayer, G Janssen, H Gadner, N Grois The Journal of pediatrics 153 (1), 127-132, 2008 | 91 | 2008 |
| Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient C Lang, P Jaksch, MA Hoda, G Lang, T Staudinger, E Tschernko, ... The Lancet Respiratory Medicine 8 (10), 1057-1060, 2020 | 86 | 2020 |
| Liquid-biopsy-based identification of EGFR T790M mutation-mediated resistance to afatinib treatment in patients with advanced EGFR mutation-positive NSCLC, and subsequent … MJ Hochmair, A Buder, S Schwab, OC Burghuber, H Prosch, W Hilbe, ... Targeted oncology 14 (1), 75-83, 2019 | 83 | 2019 |
